Liquidia (LQDA) Non Operating Income (2020 - 2026)

Liquidia's (LQDA) quarterly Non Operating Income came in at -$4.7 million in Q1 2026, down 60.5% year-on-year from -$12.0 million in Q1 2025, and up 9.75% quarter-over-quarter from -$5.2 million in Q4 2025.

Liquidia (LQDA) Non Operating Income (2020 - 2026) Analysis & Trends

Liquidia's Non Operating Income history runs 7 years deep, the most recent figure standing at -$4.7 million for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 60.5% year-over-year to -$4.7 million in Q1 2026; TTM through Mar 2026 was -$19.3 million, a 123.26% decrease from a year earlier, with the FY2025 full-year figure at -$17.5 million, down 150.79% from the prior year.
  • Non Operating Income rose to -$4.7 million in Q1 2026 per LQDA's latest filing, from -$5.2 million in the prior quarter.
  • Across five years, Non Operating Income topped out at -$36000.0 in Q4 2022 and bottomed at -$5.3 million in Q3 2025.
  • The 5-year median for Non Operating Income is -$1.5 million (2022), against an average of -$2.2 million.
  • Across the five-year window, Non Operating Income surged 82.09% in 2022 and plunged 2716.67% in 2023, its largest moves.
  • Year by year, Non Operating Income stood at -$36000.0 in 2022, then plunged by 2716.67% to -$1.0 million in 2023, then slumped by 136.98% to -$2.4 million in 2024, then sank by 117.73% to -$5.2 million in 2025, then increased by 9.75% to -$4.7 million in 2026.
  • Per Business Quant, the three latest LQDA Non Operating Income figures stand at -$4.7 million (Q1 2026), -$5.2 million (Q4 2025), and -$5.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -216.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 20.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -7.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 53.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Liquidia 7.84 Bn 7.61 Bn 121.79 Mn -4.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.72 Mn
Dec 31, 2025 -5.23 Mn
Sep 30, 2025 -5.30 Mn
Jun 30, 2025 -4.07 Mn
Mar 31, 2025 -2.94 Mn
Dec 31, 2024 -2.40 Mn
Sep 30, 2024 -1.84 Mn
Jun 30, 2024 -1.47 Mn
Mar 31, 2024 -1.28 Mn
Dec 31, 2023 -1.01 Mn
Sep 30, 2023 -899,000.00
Jun 30, 2023 -692,000.00
Mar 31, 2023 -2.51 Mn
Dec 31, 2022 -36,000.00
Sep 30, 2022 -261,000.00
Jun 30, 2022 -477,000.00
Mar 31, 2022 -1.47 Mn
Dec 31, 2021 -201,000.00
Sep 30, 2021 -201,000.00
Jun 30, 2021 -198,000.00